0001209191-17-059638.txt : 20171107
0001209191-17-059638.hdr.sgml : 20171107
20171107172638
ACCESSION NUMBER: 0001209191-17-059638
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171103
FILED AS OF DATE: 20171107
DATE AS OF CHANGE: 20171107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SMITH IAN F
CENTRAL INDEX KEY: 0001197032
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 171184485
MAIL ADDRESS:
STREET 1: C/O ACORDA THERAPEUTICS, INC.
STREET 2: 420 SAW MILL RIVER ROAD
CITY: ARDSLEY
STATE: NY
ZIP: 10502
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-11-03
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001197032
SMITH IAN F
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, COO
Common Stock
2017-11-03
4
M
0
2155
91.05
A
43043
D
Common Stock
2017-11-03
4
S
0
2155
150.00
D
40888
D
Common Stock
2017-11-06
4
M
0
4250
77.31
A
45138
D
Common Stock
2017-11-06
4
S
0
4250
150.00
D
40888
D
Common Stock
5306
I
401(k)
Stock Option (Right to Buy)
91.05
2017-11-03
4
M
0
2155
0.00
D
2026-02-01
Common Stock
2155
19397
D
Stock Option (Right to Buy)
77.31
2017-11-06
4
M
0
4250
0.00
D
2024-02-04
Common Stock
4250
4250
D
Transaction made pursuant to Mr. Smith's company-approved trading plan under Rule 10b5-1.
The option vests in 16 quarterly installments from 2/2/2016.
The option vests in 16 quarterly installments from 2/5/2014.
/s/ Omar White, Attorney-in-Fact
2017-11-07